| Year |
Citation |
Score |
| 2015 |
Kuntimaddi A, Achille NJ, Thorpe J, Lokken AA, Singh R, Hemenway CS, Adli M, Zeleznik-Le NJ, Bushweller JH. Degree of recruitment of DOT1L to MLL-AF9 defines level of H3K79 Di- and tri-methylation on target genes and transformation potential. Cell Reports. 11: 808-20. PMID 25921540 DOI: 10.1016/J.Celrep.2015.04.004 |
0.647 |
|
| 2015 |
Bushweller J, Kuntimaddi A, Thorpe J, Achille N, Lokken A, Singh R, Adli M, Zeleznik-Le N. Intrinsic Disorder, Epigenetics, and Leukemia - the MLL-AF9 SAGA Biophysical Journal. 108: 5a. DOI: 10.1016/J.Bpj.2014.11.045 |
0.692 |
|
| 2014 |
Lokken AA, Achille NJ, Chang MJ, Lin JJ, Kuntimaddi A, Leach BI, Malik B, Nesbit JB, Zhang S, Bushweller JH, Zeleznik-Le NJ, Hemenway CS. Importance of a specific amino acid pairing for murine MLL leukemias driven by MLLT1/3 or AFF1/4. Leukemia Research. 38: 1309-15. PMID 25282333 DOI: 10.1016/J.Leukres.2014.08.010 |
0.569 |
|
| 2013 |
Risner LE, Kuntimaddi A, Lokken AA, Achille NJ, Birch NW, Schoenfelt K, Bushweller JH, Zeleznik-Le NJ. Functional specificity of CpG DNA-binding CXXC domains in mixed lineage leukemia. The Journal of Biological Chemistry. 288: 29901-10. PMID 23990460 DOI: 10.1074/Jbc.M113.474858 |
0.483 |
|
| 2013 |
Kuntimaddi A, Lokken A, Zhang S, Thorpe J, Leach B, Lumba B, Hemenway CS, Adli M, Zeleznik-Le NJ, Bushweller JH. Structural and Functional Studies Of The Intrinsically Disordered Protein AF9 In MLL-AF9 Leukemia Blood. 122: 3762-3762. DOI: 10.1182/Blood.V122.21.3762.3762 |
0.668 |
|
| 2012 |
Lokken AA, Zeleznik-Le NJ. Breaking the LSD1/KDM1A addiction: therapeutic targeting of the epigenetic modifier in AML. Cancer Cell. 21: 451-3. PMID 22516254 DOI: 10.1016/J.Ccr.2012.03.027 |
0.554 |
|
| Show low-probability matches. |